Charles Schwab Investment Management »

ADC Therapeutics SA shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $387k 194k 1.99
2024-09-30 $612k 194k 3.15
2024-06-30 $555k 176k 3.16

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Us S (FNDA)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Home Depot (HD)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Woodline Partners
Silverarc Capital Management
Goldman Sachs Group
Platinum Investment Mangement
Bank of America Corporation
State Street Corporation
Siren
Geode Capital Management
UBS Group
Vantage Consulting Group

View all funds holding ADC Therapeutics SA